טוען...
Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia
AIM: To assess the efficacy and safety of an intravitreal injection of bevacizumab (Avastin®) for myopic choroidal neovascularisation (mCNV). METHODS: Intravitreal bevacizumab (1 mg) was injected into eight eyes of eight patients with mCNV in this non‐randomised, interventional case series. The best...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1857602/ https://ncbi.nlm.nih.gov/pubmed/16914470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.099887 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|